A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis

Mark Patrick Nicol1, Devasena Gnanashanmugam2, Renee Browning2

  • 1Division of Medical Microbiology and Institute for Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service of South Africa.

Insights

Diagnosing childhood tuberculosis (TB) is difficult due to poor pathogen detection and lack of specific biomarkers. A National Institutes of Health workshop outlined research priorities to improve pediatric TB diagnosis and care.

Area of Science:

  • Pediatric infectious diseases
  • Mycobacterium tuberculosis diagnostics
  • Biomarker discovery

Background:

  • Childhood tuberculosis (TB) presents a significant global health burden.
  • Current diagnostic methods for pediatric TB are inadequate, particularly in paucibacillary cases.
  • There is a lack of child-specific host biomarkers for TB identification.

Purpose of the Study:

  • To address the critical research gap in diagnosing childhood tuberculosis.
  • To delineate research priorities for advancing pediatric TB diagnostics.
  • To foster harmonization and collaboration in the field.

Main Methods:

  • Convened a National Institutes of Health (NIH) workshop in May 2014.
  • Brought together researchers in the field of childhood tuberculosis.
  • Developed a consensus blueprint outlining research priorities and critical steps.

Main Results:

  • Identified key research priorities to improve pediatric TB diagnosis.
  • Outlined critical research steps needed to advance the field.
  • Established a foundation for collaborative efforts in pediatric TB research.

Conclusions:

  • Improving the diagnosis of childhood TB is essential for better case detection and public health.
  • The workshop provided a roadmap for future research and development in pediatric TB.
  • Harmonization and collaboration are crucial for overcoming challenges in childhood TB diagnosis.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
707
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
870
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K